![](/img/cover-not-exists.png)
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
Yang, H., Bouma, B.J., Dimopoulos, K., Khairy, P., Ladouceur, M., Niwa, K., Greutmann, M., Schwerzmann, M., Egbe, A., Scognamiglio, G., Budts, W., Veldtman, G., Opotowsky, A.R., Broberg, C.S., GumbienLanguage:
english
Journal:
International Journal of Cardiology
DOI:
10.1016/j.ijcard.2019.06.014
Date:
June, 2019
File:
PDF, 989 KB
english, 2019